Common Stock, Shares, Outstanding of Travere Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Travere Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Travere Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 90,922,868, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Travere Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 90,922,868 +3,470,033 +4% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 89,456,626 +11,547,584 +15% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 89,102,347 +12,645,785 +17% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 88,787,429 +12,678,600 +17% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 87,452,835 +12,085,718 +16% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 77,909,042 +2,797,525 +3.7% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 76,456,562 +1,484,755 +2% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 76,108,829 +1,522,023 +2% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 75,367,117 +11,076,547 +17% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 75,111,517 +10,961,007 +17% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 74,971,807 +11,133,757 +17% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 74,586,806 +11,076,529 +17% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 64,290,570 +1,799,072 +2.9% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 64,150,510 +3,132,281 +5.1% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 63,838,050 +3,127,174 +5.2% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 63,510,277 +3,074,547 +5.1% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 62,491,498 +10,243,067 +20% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 61,018,229 +9,995,042 +20% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 60,710,876 +9,808,002 +19% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 60,435,730 +17,282,515 +40% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 52,248,431 +9,159,510 +21% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 51,023,187 +8,064,786 +19% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 50,902,874 +8,003,556 +19% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 43,153,215 +1,715,195 +4.1% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 43,088,921 +1,699,397 +4.1% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 42,958,401 +1,790,459 +4.3% 30 Sep 2019 10-Q 30 Oct 2019 2019 Q3
Q2 2019 42,899,318 +2,528,797 +6.3% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 41,438,020 +1,564,735 +3.9% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 41,389,524 +2,015,779 +5.1% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q3 2018 41,167,942 +1,887,240 +4.8% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 40,370,521 +2,079,645 +5.4% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 39,873,285 +1,711,861 +4.5% 31 Mar 2018 10-Q 06 Jul 2018 2018 Q1
Q4 2017 39,373,745 +1,467,076 +3.9% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 39,280,702 +1,576,706 +4.2% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 38,290,876 +1,565,746 +4.3% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 38,161,424 +1,568,989 +4.3% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 37,906,669 +1,440,816 +4% 31 Dec 2016 10-K 06 Jul 2018 2017 FY
Q3 2016 37,703,996 +1,695,900 +4.7% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 36,725,130 +1,652,373 +4.7% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 36,592,435 +1,746,985 +5% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 36,465,853 +10,417,373 +40% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 36,008,096 +9,687,840 +37% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 35,072,757 +8,770,834 +33% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 34,845,450 +10,423,099 +43% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 26,048,480 +7,632,907 +41% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 26,320,256 +7,943,893 +43% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 26,301,923 +13,979,950 +113% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 24,422,351 +12,231,711 +100% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 18,415,573 +9,462,668 +106% 31 Dec 2013 10-K/A 09 Jul 2015 2013 FY
Q3 2013 18,376,363 30 Sep 2013 10-Q/A 09 Jul 2015 2013 Q3
Q2 2013 12,321,973 30 Jun 2013 10-Q 16 Sep 2013 2013 Q2
Q1 2013 12,190,640 +12,083,945 +11326% 31 Mar 2013 10-Q/A 16 Sep 2013 2013 Q1
Q4 2012 8,952,905 +4,910,640 +121% 31 Dec 2012 10-K/A 09 Jul 2015 2013 FY
Q1 2012 106,695 29 Feb 2012 10-Q 06 Mar 2013 2012 Q3
Q4 2011 4,042,265 31 Dec 2011 10-K/A 16 Sep 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.